Inhibition	O
of	O
energy	O
-	O
producing	O
pathways	O
of	O
HepG2	B-Cell
cells	I-Cell
by	O
3	O
-	O
bromopyruvate	O
.	O

3	O
-	O
BrPA	O
(	O
3	O
-	O
bromopyruvate	O
)	O
is	O
an	O
alkylating	O
agent	O
with	O
anti	O
-	O
tumoral	B-Cancer
activity	O
on	O
hepatocellular	B-Cancer
carcinoma	I-Cancer
.	O

This	O
compound	O
inhibits	O
cellular	B-Cell
ATP	O
production	O
owing	O
to	O
its	O
action	O
on	O
glycolysis	O
and	O
oxidative	O
phosphorylation	O
;	O
however	O
,	O
the	O
specific	O
metabolic	O
steps	O
and	O
mechanisms	O
of	O
3	O
-	O
BrPA	O
action	O
in	O
human	O
hepatocellular	B-Cancer
carcinomas	I-Cancer
,	O
particularly	O
its	O
effects	O
on	O
mitochondrial	B-Cellular_component
energetics	O
,	O
are	O
poorly	O
understood	O
.	O

In	O
the	O
present	O
study	O
it	O
was	O
found	O
that	O
incubation	O
of	O
HepG2	B-Cell
cells	I-Cell
with	O
a	O
low	O
concentration	O
of	O
3	O
-	O
BrPA	O
for	O
a	O
short	O
period	O
(	O
150	O
microM	O
for	O
30	O
min	O
)	O
significantly	O
affected	O
both	O
glycolysis	O
and	O
mitochondrial	B-Cellular_component
respiratory	O
functions	O
.	O

The	O
activity	O
of	O
mitochondrial	B-Cellular_component
hexokinase	O
was	O
not	O
inhibited	O
by	O
150	O
microM	O
3	O
-	O
BrPA	O
,	O
but	O
this	O
concentration	O
caused	O
more	O
than	O
70	O
%	O
inhibition	O
of	O
GAPDH	O
(	O
glyceraldehyde	O
-	O
3	O
-	O
phosphate	O
dehydrogenase	O
)	O
and	O
3	O
-	O
phosphoglycerate	O
kinase	O
activities	O
.	O

Additionally	O
,	O
3	O
-	O
BrPA	O
treatment	O
significantly	O
impaired	O
lactate	O
production	O
by	O
HepG2	B-Cell
cells	I-Cell
,	O
even	O
when	O
glucose	O
was	O
withdrawn	O
from	O
the	O
incubation	O
medium	O
.	O

Oxygen	O
consumption	O
of	O
HepG2	B-Cell
cells	I-Cell
supported	O
by	O
either	O
pyruvate	O
/	O
malate	O
or	O
succinate	O
was	O
inhibited	O
when	O
cells	B-Cell
were	O
pre	O
-	O
incubated	O
with	O
3	O
-	O
BrPA	O
in	O
glucose	O
-	O
free	O
medium	O
.	O

On	O
the	O
other	O
hand	O
,	O
when	O
cells	B-Cell
were	O
pre	O
-	O
incubated	O
in	O
glucose	O
-	O
supplemented	O
medium	O
,	O
oxygen	O
consumption	O
was	O
affected	O
only	O
when	O
succinate	O
was	O
used	O
as	O
the	O
oxidizable	O
substrate	O
.	O

An	O
increase	O
in	O
oligomycin	O
-	O
independent	O
respiration	O
was	O
observed	O
in	O
HepG2	B-Cell
cells	I-Cell
treated	O
with	O
3	O
-	O
BrPA	O
only	O
when	O
incubated	O
in	O
glucose	O
-	O
supplemented	O
medium	O
,	O
indicating	O
that	O
3	O
-	O
BrPA	O
induces	O
mitochondrial	B-Cellular_component
proton	O
leakage	O
as	O
well	O
as	O
blocking	O
the	O
electron	O
transport	O
system	O
.	O

The	O
activity	O
of	O
succinate	O
dehydrogenase	O
was	O
inhibited	O
by	O
70	O
%	O
by	O
3	O
-	O
BrPA	O
treatment	O
.	O

These	O
results	O
suggest	O
that	O
the	O
combined	O
action	O
of	O
3	O
-	O
BrPA	O
on	O
succinate	O
dehydrogenase	O
and	O
on	O
glycolysis	O
,	O
inhibiting	O
steps	O
downstream	O
of	O
the	O
phosphorylation	O
of	O
glucose	O
,	O
play	O
an	O
important	O
role	O
in	O
HepG2	B-Cell
cell	I-Cell
death	O
.	O

